Summary
SOPHiA Genetics: Strong Growth Meets A Critical Execution Phase
SOPHiA GENETICS is approaching an inflection point in precision medicine, leveraging AI-driven genomic analysis as sequencing costs decline and data complexity rises. SOPH's platform benefits from a self-reinforcing data flywheel, with 2.5 million genomic profiles and 537 institutions using SOPHiA DDM across 75 countries. Revenue grew 22% year-over-year to $21.7M in 1Q26, with 117% net dollar retention and adjusted gross margin of 75.4%, but profitability remains a key watchpoint.
SOPHiA GENETICS SA (SOPH) Q1 2026 Earnings Call Transcript
SOPHiA GENETICS SA (SOPH) Q1 2026 Earnings Call Transcript
SOPHiA GENETICS (NASDAQ:SOPH) & Hims & Hers Health (NYSE:HIMS) Financial Comparison
Hims and Hers Health (NYSE: HIMS - Get Free Report) and SOPHiA GENETICS (NASDAQ: SOPH - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings. Valuation and Earnings This table compares
SOPHiA GENETICS SA Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 61 | $301.95 | $387.35 | $85.4 | 28.28% |
 Akre Capital Management Akre Capital Management LLC | 3.72M | $14.55M | $23.58M | $9.03M | 62.1% |
| PF Phillip Fitzsimmons Hennion & Walsh Asset Management Inc. | 98,347 | $588,115.06 | $622,536.51 | $34,421.45 | 5.85% |
| CAL CoreCap Advisors LLC CoreCap Advisors LLC | 490 | $2,930.2 | $3,101.7 | $171.5 | 5.85% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 1 | $5 | $6.33 | $1.33 | 26.6% |
SOPHiA GENETICS SA Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Mark Massaro BTIG | 305.85 | $1,632.91 | $1,749.43 | $116.52 | 7.14% |
SOPHiA GENETICS SA (SOPH) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has SOPHiA GENETICS SA ever had a stock split?
SOPHiA GENETICS SA Profile
| Health Care Technology Industry | Healthcare Sector | Ross Muken CEO | NASDAQ (NGS) Exchange | H82027105 CUSIP |
| CH Country | 415 Employees | - Last Dividend | - Last Split | 23 Jul 2021 IPO Date |
Overview
SOPHiA GENETICS SA stands out as a pioneering cloud-native software technology company within the healthcare sector, specializing in the complex analysis of data to derive meaningful insights. Founded in 2011 with its headquarters in Rolle, Switzerland, SOPHiA GENETICS has quickly become a notable entity for leveraging cloud technology to facilitate advancements in healthcare analytics. The company's reach spans a global network, providing services through its direct sales force, distributors, and industry collaborators across various regions including Switzerland, France, Italy, the rest of Europe, North America (with a specific focus on the United States), Latin America, and the Asia-Pacific region. By marrying innovative technology with comprehensive data analysis, SOPHiA GENETICS is redefining the approach to healthcare diagnostics and research, making significant strides toward the future of personalized medicine and enhanced patient care.
Products and Services
- SOPHiA DDM Platform
- Related Solutions, Applications, Products, and Services
A sophisticated cloud-native software platform designed by SOPHiA GENETICS to offer unparalleled analysis of multimodal data sets and diagnostic modalities. This platform serves as the foundation for generating actionable insights, propelling the use of data-driven decision-making in healthcare. Aimed at transforming raw data into meaningful information, the SOPHiA DDM Platform is crucial for hospitals, laboratories, and biopharmaceutical companies striving toward the advancement of personalized medicine and better health outcomes.
In addition to the SOPHiA DDM platform, SOPHiA GENETICS offers a comprehensive range of related solutions, applications, products, and services tailored to meet the diverse needs of the healthcare industry. These offerings are designed to enhance the capabilities of the SOPHiA DDM platform, ensuring that clients have access to a full suite of tools for diagnostics, research, and development. The expansive availability of these sophisticated solutions demonstrates SOPHiA GENETICS's commitment to supporting healthcare professionals and researchers in their quests to uncover groundbreaking findings and improve patient care across the globe.
